Aramark (ARMK) files Amendment No.18 to add Term B-9 tranche; no quarterly principal
Rhea-AI Filing Summary
Aramark disclosed Amendment No. 18 to its Credit Agreement dated March 28, 2017, effected August 15, 2025, which adds U.S. Term B-9 Loans. The U.S. Term B-9 Loans bear interest either at (a) a Eurodollar-type rate plus an initial margin of 1.75% or (b) a base rate tied to the highest of the administrative agent's prime rate, the federal funds rate plus 0.50%, and Term SOFR for a one-month interest period plus 1.00%, plus an initial margin of 0.75%. The U.S. Term B-9 Loans do not require quarterly principal repayments and are subject to substantially similar guarantees, collateral, mandatory prepayments and covenants as the previously outstanding U.S. Term B-7 Loans and the company's other U.S. Term B Loans under the Credit Agreement.
Positive
- New term tranche introduced under the existing Credit Agreement provides explicit borrowing mechanics for U.S. Term B-9 Loans
- Interest-rate flexibility with two rate options (Eurodollar-type + 1.75% margin or base-rate option + 0.75% margin)
- No quarterly principal repayments required for the U.S. Term B-9 Loans, which preserves near-term cash flow flexibility
- Consistent security and covenant framework—B-9 Loans are subject to substantially similar guarantees, collateral, mandatory prepayments and covenants as prior B loans
Negative
- Document does not disclose principal amount or maturity for the U.S. Term B-9 Loans, limiting assessment of debt load and refinancing risk
- No covenant thresholds or financial metric impacts provided, so investor assessment of leverage or compliance effects is not possible from this text alone
Insights
TL;DR: Amendment adds new U.S. Term B-9 facility with floating-rate options, unchanged structural protections, and no quarterly principal amortization.
The amendment formalizes additional term debt under the existing credit framework, preserving the same guarantee, collateral and covenant architecture that applied to the prior U.S. Term B-7 Loans. Borrowing costs are variable with two rate alternatives: a Eurodollar-type rate plus an initial margin of 1.75% or a base-rate option tied to prime/federal-funds/SOFR plus an initial margin of 0.75%. The absence of required quarterly principal repayments for the B-9 tranche affects cash flow scheduling but the filing does not disclose the aggregate principal amount, maturity, or covenant thresholds, so full credit impact cannot be assessed from this text alone.
TL;DR: Amendment reflects routine credit agreement modification adding a new term tranche while maintaining existing security and covenant terms.
The document indicates the company and certain subsidiaries, alongside JPMorgan Chase Bank, N.A. as administrative and collateral agent, executed Amendment No. 18 to the existing credit agreement. Key commercial mechanics—interest rate alternatives with specified initial margins and parity of guarantees, collateral and covenants with prior term loans—are explicitly stated. The filing omits material quantitative details such as borrowed amount, maturity date, and covenant metrics; therefore, governance and investor implications are limited to the structural changes disclosed.